Chempass Company
ChemPass was founded to develop AI technologies and software for the design of novel small organic molecules and scaffolds. ChemPass' technologies utilize synthetic artificial intelligence for template design, in silico reaction planning and evaluation, a chemistry know-how database and several other custom solutions.
%20.jpg)
Investor Type:
N/A
Technology:
Drug Design
Investment Stage:
N/A
Founded Date:
2016
Industry:
Drug Discovery
Employee Number:
Undisclosed
Funding Status:
Seed
Number Of Exists:
N/A
Headquarters:
Budapest, Budapest, Hungary